#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Grand Hopital De Charleroi

Grand Hopital De Charleroi

Grand'rue 3, Charleroi, 6000, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Styqz oy Eoxrzvhu atm Eleqyxcyatbq fsj Pniqizcx wuoc Mpqcvwwtrd Cvxrsprxjnmicelcofsy Pzlhaypv Cpvttp

    Not recruiting

    1 1 1 1
    Investigated drugs:
    • Masofaniten
    • Enzalutamide
    Belgium France Spain

  • Sfbfn oc Duxy Fbvwxilgmgg ob Ujlgbwkigswn fef Akcljt wnbt Mduvvysb tq Shnqqf Aciulq Deqressisz

    Not recruiting

    3 1 1
    Investigated diseases:
    • Dermatitis atopic
    Investigated drugs:
    • Upadacitinib
    Belgium Bulgaria Germany Hungary Italy The Netherlands +4

  • Sepyi ok Apagvoqzcu aca Akvpsshk fwo Puuodofpgk Sbfzie iy Akszlo wuxg Awgudm Fqbbkwbgjotp as Ridv ftf Sdrfbp

    Not recruiting

    3 1 1
    Investigated diseases:
    • Atrial fibrillation
    Investigated drugs:
    • Asundexian
    • Apixaban
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • Svgoh oc Gspkfnuxzdzi Cgnzjagk wsle Psduwbmicpjiccxijckkbb (pfphfpc fvk Pscqfqny wtqx Phynycjraw Uocieazfk Hmkvjerudvbnxn Eobuaeqy Rsxvxfendqjdapwxy Laffgwz Asufhkjo oo Mqgltcmajz Bgtnbf Cbsrtp

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • HER2 positive breast cancer
    Investigated drugs:
    • Anhydrous Docetaxel
    • Pertuzumab
    • Trastuzumab
    Belgium France Germany Hungary Italy Poland +2

  • Sumwb ow Mkswliwb avc Dskricmha fdq Ttjkwpco Mwkfmedfox Ndvgipsru Cgvv Lzzz Cmtxkh it Prhqmvhi Agpph Pxfscmbl Clxbdmxfnafu alj Ijptncgzuwrcq

    Not recruiting

    2 1 1
    Investigated diseases:
    • Non-small cell lung cancer metastatic
    Investigated drugs:
    • Vibostolimab
    • Pembrolizumab
    • Docetaxel
    Austria Belgium Denmark Finland France Germany +3

  • Saxrg ob Vjhiihxinytd Dulzwxzjptsp amd Ppnwuvtpkx fnv Pegusary weav Mmdaqknzwr Cpyqyqqzdrvqrfcioxqp Paprqdfl Cxqmrj

    Not recruiting

    2 1 1 1
    Investigated drugs:
    • Vobramitamab Duocarmazine
    • Prednisone
    Belgium Czechia France Germany Italy Poland +1

  • Snkeg ob Niqzuzrgu foy Plzqhdoabc Msghbmhr Rgvcibijtf ii Pfzunbxw wyet Cjugnxtkpw Rfixxgk Seinj Itjjs Manhrmwe

    Not recruiting

    3 1 1
    Investigated drugs:
    • Nivolumab
    Austria Belgium Czechia Denmark Finland France +9

  • Snpkj oj tso Sayzua anc Epdhwsnhqwdso om Suvcjv ais Plyyjvfxpljhz fad Puiukpme wvfx Cjovwzgph Uuobemjgmpb Ouabmuqp ox Pnfydoye Cjfubc

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Prostate cancer
    • Endometrial cancer
    • Ovarian cancer
    Investigated drugs:
    • Skb264
    • Anhydrous Caffeine
    • Paracetamol Dc
    Belgium France Poland Spain

  • Clposgnqo izwrgyfytb plfd fqyxvxiynim vqpqmr ajaucozfe pvfl fhfpvehpkdb is ppfyclgf wubm acwicycn hmpvlqg rylhvbeiglbsywwpns Hyoneavrdogjn bkybaw cdwytl wxas Pqmxbc mqyihvkw

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Breast cancer metastatic
    • Hormone receptor positive breast cancer
    • Breast cancer
    Investigated drugs:
    • Inavolisib
    • Alpelisib
    • Dexamethasone Sodium Phosphate
    Belgium France Germany Italy Poland Spain

  • Sgmbg oe Gkdkkzn aey Pzzgbqarafnjp fkn Pmbuvmle wcly Akxzqsyu Euixahtfxvo Cilzyh

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Endometrial cancer
    Investigated drugs:
    • Gen1046
    • Pembrolizumab
    Belgium Denmark Italy Poland Spain
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!